Literature DB >> 12740792

Hepatic allograft-derived Kupffer cells regulate T cell response in rats.

Zhaoli Sun1, Tatehiko Wada, Kosei Maemura, Keiichiro Uchikura, Sumito Hoshino, Anna Mae Diehl, Andrew S Klein.   

Abstract

In liver transplantation, the development of tolerance is associated with an increased rate of apoptosis of T lymphocytes in the portal inflammatory infiltrate and the presence of an intragraft Th2-like T cell population. Underlying mechanisms are poorly understood. Kupffer cells (KC), which reside in the hepatic sinosoids, can directly interact with circulating T lymphocytes and thus are uniquely positioned to play a role in immunomodulation. In this study, the immunoregulatory effects of KC were investigated. We show that KC can significantly suppress T cell proliferation in mixed leukocyte reaction (MLR). Furthermore, KC express functional Fas ligand (FasL) and can induce apoptosis of Fas+ cells. This process can be blocked by addition of neutralizing anti-FasL antibody. Moreover, using an allogeneic liver transplant model we have determined that 1. KC recovered from chronically accepted hepatic allografts have increased FasL messenger RNA (mRNA) and protein expression and a greater ability to induce apoptosis of alloreactive T cells compared with KC recovered from an acute rejection model; 2. KC not only induce apoptosis of T cells, but also regulate cytokine production and Th2/Th3-like cytokine (interleukin [IL]-10 / transforming growth factor [TGF]-beta) mRNA expression in allogeneic MLR in vitro; and 3. administration of KC derived from chronically accepted liver allografts significantly prolongs the survival of hepatic allografts in an acute rejection model in an alloantigen-specific manner. In conclusion, these data implicate the possible role of KC-mediated regulation of T cell response in the induction of immune tolerance in liver allografts.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12740792     DOI: 10.1053/jlts.2003.50091

Source DB:  PubMed          Journal:  Liver Transpl        ISSN: 1527-6465            Impact factor:   5.799


  16 in total

1.  Mac the knife? Macrophages- the double-edged sword of hepatic fibrosis.

Authors:  Scott L Friedman
Journal:  J Clin Invest       Date:  2005-01       Impact factor: 14.808

2.  Isolation of Kupffer cells and their suppressive effects on T lymphocyte growth in rat orthotopic liver transplantation.

Authors:  Hua Liu; Hui Cao; Zhi-Yong Wu
Journal:  World J Gastroenterol       Date:  2007-06-14       Impact factor: 5.742

Review 3.  Macrophages in hepatitis B and hepatitis C virus infections.

Authors:  Mathis Heydtmann
Journal:  J Virol       Date:  2008-10-08       Impact factor: 5.103

4.  Inhibition of allogeneic T-cell response by Kupffer cells expressing indoleamine 2,3-dioxygenase.

Authors:  Mao-Lin Yan; Yao-Dong Wang; Yi-Feng Tian; Zhi-De Lai; Lv-Nan Yan
Journal:  World J Gastroenterol       Date:  2010-02-07       Impact factor: 5.742

5.  FasL expression in hepatic antigen-presenting cells and phagocytosis of apoptotic T cells by FasL+ Kupffer cells are indicators of rejection activity in human liver allografts.

Authors:  Aya Miyagawa-Hayashino; Tatsuaki Tsuruyama; Hiroto Egawa; Hironori Haga; Hiromi Sakashita; Tomoko Okuno; Shinya Toyokuni; Keiji Tamaki; Hirohiko Yamabe; Toshiaki Manabe; Shinji Uemoto
Journal:  Am J Pathol       Date:  2007-09-06       Impact factor: 4.307

6.  Activation of innate immunity (NK/IFN-gamma) in rat allogeneic liver transplantation: contribution to liver injury and suppression of hepatocyte proliferation.

Authors:  Kezhen Shen; Shu-Sen Zheng; Ogyi Park; Hua Wang; Zhaoli Sun; Bin Gao
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2008-02-21       Impact factor: 4.052

7.  Loss of Kupffer cells in diet-induced obesity is associated with increased hepatic steatosis, STAT3 signaling, and further decreases in insulin signaling.

Authors:  Alicia H Clementi; Allison M Gaudy; Nico van Rooijen; Robert H Pierce; Robert A Mooney
Journal:  Biochim Biophys Acta       Date:  2009-08-20

Review 8.  Specific CD8(+) T cell response immunotherapy for hepatocellular carcinoma and viral hepatitis.

Authors:  Elia Moreno-Cubero; Juan-Ramón Larrubia
Journal:  World J Gastroenterol       Date:  2016-07-28       Impact factor: 5.742

9.  Immune tolerance in liver disease.

Authors:  Ian N Crispe
Journal:  Hepatology       Date:  2014-09-26       Impact factor: 17.425

10.  MicroRNA let-7a ameliorates con A-induced hepatitis by inhibiting IL-6-dependent Th17 cell differentiation.

Authors:  Yingying Zhang; Xiangmin Wang; Min Zhong; Mengying Zhang; Qifeng Suo; Kun Lv
Journal:  J Clin Immunol       Date:  2012-11-27       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.